Latest Breaking News On - Ironwood pharmaceuticals - Page 6 : comparemela.com

Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024

– Data from pivotal Phase III STARS study in short bowel syndrome with intestinal failure accepted as late-breaker oral presentation on May 21 at 10:30 am ET – – Findings from the STARS.

United statesMichael shetzlineIronwood pharmaceuticals nasdaqExchange commissionA national survey analysisIronwood pharmaceuticalsIronwood pharmaceuticals incCenter trialDrug administrationDisease weekApraglutide once weeklyShort bowel syndromeIntestinal failureGlobal phasePlacebo controlled trialBowel morphology

Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week 2024

01.05.2024 - Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that the company will present new data from studies evaluating apraglutide in adults with short bowel syndrome with intestinal failure (SBS-IF), a . Seite 1

Michael shetzlineDrug administrationCenter trialIronwood pharmaceuticalsApraglutide once weeklyShort bowel syndromeIntestinal failureGlobal phasePlacebo controlled trialBowel morphologyMotility assessedShort bowel syndrome intestinal failureColon in continuity treatedSupport weaningClinical benefitImproved patient reported outcomes

SAP revenue grows 8% to €8,041 million in first-quarter

SAP revenue grows 8% to €8,041 million in first-quarter
infotechlead.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infotechlead.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaUnited arab emiratesBruxelles capitaleBaden wübergSouth islandCh ungch ong namdoIneos europeChristian kleinBrussels regional public servicePublic power corporationZf friedrichshafenSchaeffler groupKorea chamberVaillant groupSumitomo heavy industries

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 5 5% Higher

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) shares traded up 5.5% during trading on Wednesday . The stock traded as high as $8.19 and last traded at $8.18. 351,520 shares were traded during mid-day trading, a decline of 92% from the average session volume of 4,272,103 shares. The stock had previously closed at $7.75. […]

New yorkUnited statesSaudi arabiaPiper sandlerJonr duaneMichael shetzlineCraig hallumChina universal asset management coPrincipal financial group incMirae asset global investments coSecurities exchange commissionIronwood pharmaceuticals incIronwood pharmaceuticals company profileIronwood pharmaceuticalsWells fargo companyIronwood pharmaceuticals stock performance

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGreg martiniMatt roacheIronwood pharmaceuticals incIronwood pharmaceuticals nasdaqIronwood pharmaceuticals